NCT03849261View on ClinicalTrials.gov

Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 14, 2019

Primary Completion Date

February 1, 2019

Study Completion Date

February 22, 2019

Conditions
Type2 Diabetes Mellitus
Interventions
DRUG

CKD-387

Test drug

DRUG

D635

Reference drug

Trial Locations (1)

03722

Severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT03849261 - Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | Biotech Hunter | Biotech Hunter